{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T20:06:04Z","timestamp":1792181164545,"version":"4.4.0"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2021,1,21]],"date-time":"2021-01-21T00:00:00Z","timestamp":1611187200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,1,21]],"date-time":"2021-01-21T00:00:00Z","timestamp":1611187200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"Ministry of Industry and Trade of the Russian Federation"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Antibiot"],"published-print":{"date-parts":[[2021,4]]},"DOI":"10.1038\/s41429-020-00396-w","type":"journal-article","created":{"date-parts":[[2021,1,21]],"date-time":"2021-01-21T01:02:33Z","timestamp":1611190953000},"page":"244-254","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":39,"title":["Fluorothiazinon, a small-molecular inhibitor of T3SS, suppresses salmonella oral infection in mice"],"prefix":"10.1038","volume":"74","author":[{"given":"Nailya A.","family":"Zigangirova","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8893-5702","authenticated-orcid":false,"given":"Ludmila N.","family":"Nesterenko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5210-5010","authenticated-orcid":false,"given":"Anna B.","family":"Sheremet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna V.","family":"Soloveva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergey I.","family":"Luyksaar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Egor S.","family":"Zayakin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Denis V.","family":"Balunets","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandr L.","family":"Gintsburg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,1,21]]},"reference":[{"key":"396_CR1","doi-asserted-by":"publisher","first-page":"4679","DOI":"10.1111\/jcmm.14354","volume":"23","author":"LV Qianghua","year":"2019","unstructured":"Qianghua LV, et al. Inhibition of the type III secretion system by syringaldehyde protects mice from Salmonella enterica serovar Typhimurium. J Cell Mol Med. 2019;23:4679\u201388.","journal-title":"J Cell Mol Med"},{"key":"396_CR2","first-page":"1","volume":"32","author":"O Gal-Mor","year":"2019","unstructured":"Gal-Mor O. Persistent infection and long-term carriage of typhoidal and nontyphoidal Salmonellae. Clin Microbiol Rev. 2019;32:1\u201331.","journal-title":"Clin Microbiol Rev"},{"key":"396_CR3","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.mib.2014.10.010","volume":"23","author":"LA Knodler","year":"2015","unstructured":"Knodler LA. Salmonella enterica: living a double life in epithelial cells. Curr Opin Microbiol. 2015;23:23\u201331.","journal-title":"Curr Opin Microbiol"},{"key":"396_CR4","unstructured":"WHO. Global priority list of antibiotic-resistant bacteria to guide research, discovery, and development of new antibiotics 2017. https:\/\/www.who.int\/news-room\/detail\/27-02-2017-who-publishes-list-of-bacteria-for-which-new-antibiotics-are-urgently-needed."},{"key":"396_CR5","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1016\/S1473-3099(15)00466-1","volume":"16","author":"L Czaplewski","year":"2016","unstructured":"Czaplewski L, et al. Alternatives to antibiotics-a pipeline portfolio review. Lancet Infect Dis. 2016;16:239\u201351.","journal-title":"Lancet Infect Dis"},{"key":"396_CR6","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1016\/j.tips.2017.02.003","volume":"38","author":"J Munguia","year":"2017","unstructured":"Munguia J, Nizet V. Pharmacological targeting of the host-pathogen interaction: alternatives to classical antibiotics to combat drug-resistant superbugs. Trends Pharm Sci. 2017;38:473\u201388.","journal-title":"Trends Pharm Sci"},{"key":"396_CR7","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1038\/nrmicro3232","volume":"12","author":"RC Allen","year":"2014","unstructured":"Allen RC, Popat R, Diggle SP, Brown SP. Targeting virulence: can we make evolution-proof drugs? Nat Rev Microbiol. 2014;12:300\u20138.","journal-title":"Nat Rev Microbiol"},{"key":"396_CR8","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.chom.2019.06.004","volume":"26","author":"U Theuretzbacher","year":"2019","unstructured":"Theuretzbacher U, Piddock LJV. Non-traditional antibacterial therapeutic options and challenges. Cell Host Microbe. 2019;26:61\u201372.","journal-title":"Cell Host Microbe"},{"key":"396_CR9","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1111\/cbdd.12422","volume":"85","author":"AC McShan","year":"2015","unstructured":"McShan AC, De, Guzman RN. The bacterial type III secretion system as a target for developing new antibiotics. Chem Biol Drug Des. 2015;85:30\u201342.","journal-title":"Chem Biol Drug Des"},{"key":"396_CR10","doi-asserted-by":"publisher","unstructured":"Fasciano AC, Shaban L, Mecsas J. Promises and challenges of the type three secretion system injectisome as an antivirulence target. In: Sandkvist M, Cascales E, Christie PJ, editors. Protein Secretion in Bacteria. Chapter 21. Wiley Online Library: https:\/\/doi.org\/10.1128\/9781683670285. 2019; p. 261\u2013276","DOI":"10.1128\/9781683670285"},{"key":"396_CR11","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1517\/17460441.2015.1019860","volume":"10","author":"N Charro","year":"2015","unstructured":"Charro N, Mota LJ. Approaches targeting the type III secretion system to treat or prevent bacterial infections. Expert Opin Drug Discov. 2015;10:373\u201387.","journal-title":"Expert Opin Drug Discov"},{"key":"396_CR12","doi-asserted-by":"publisher","first-page":"5433","DOI":"10.1128\/AAC.00975-12","volume":"56","author":"MC Duncan","year":"2012","unstructured":"Duncan MC, Linington RG, Auerbuch V. Chemical inhibitors of the type three secretion system: disarming bacterial pathogens. Antimicrob Agents Chemother. 2012;56:5433\u201341.","journal-title":"Antimicrob Agents Chemother"},{"key":"396_CR13","first-page":"149","volume":"14","author":"Y Zhang","year":"2018","unstructured":"Zhang Y, Liu Y, Wang T, Deng X, Chu X. Natural compound sanguinarine chloride targets the type III secretion system of Salmonella enterica Serovar Typhimurium. Biochem Biophys Rep. 2018;14:149\u201354.","journal-title":"Biochem Biophys Rep"},{"key":"396_CR14","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1038\/ja.2015.131","volume":"69","author":"LN Nesterenko","year":"2016","unstructured":"Nesterenko LN, et al. A small-molecule compound belonging to a class of 2,4-disubstituted 1,3,4-thiadiazine-5-ones suppresses Salmonella infection in vivo. J Antibiot. 2016;69:422\u20137.","journal-title":"J Antibiot"},{"key":"396_CR15","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1099\/jmm.0.000189","volume":"65","author":"NA Zigangirova","year":"2016","unstructured":"Zigangirova NA, et al. A small-molecule compound belonging to a class of 2,4-disubstituted 1,3,4-thiadiazine-5-ones inhibits intracellular growth and persistence of Chlamydia trachomatis. J Med Microbiol. 2016;65:91\u20138.","journal-title":"J Med Microbiol"},{"key":"396_CR16","doi-asserted-by":"publisher","first-page":"484853","DOI":"10.1155\/2015\/484853","volume":"2015","author":"EA Koroleva","year":"2015","unstructured":"Koroleva EA, et al. Small molecule inhibitor of type three secretion suppresses acute and chronic Chlamydia trachomatis infection in a novel urogenital Chlamydia model. Biomed Res Int. 2015;2015:484853.","journal-title":"Biomed Res Int"},{"key":"396_CR17","doi-asserted-by":"publisher","first-page":"87","DOI":"10.32607\/20758251-2012-4-2-87-97","volume":"4","author":"NA Zigangirova","year":"2012","unstructured":"Zigangirova NA, et al. Development of Chlamydial type III secretion system inhibitors for suppression of acute and chronic forms of Chlamydial infection. Acta Nat. 2012;4:87\u201397.","journal-title":"Acta Nat"},{"key":"396_CR18","doi-asserted-by":"publisher","first-page":"5810767","DOI":"10.1155\/2018\/5810767","volume":"2018","author":"AB Sheremet","year":"2018","unstructured":"Sheremet AB, et al. Small molecule inhibitor of type three secretion system belonging to a class 2,4-disubstituted-4h-[1,3,4]-thiadiazine-5-ones improves survival and decreases bacterial loads in an airway Pseudomonas aeruginosa infection in mice. Biomed Res Int. 2018;2018:5810767.","journal-title":"Biomed Res Int"},{"key":"396_CR19","doi-asserted-by":"publisher","first-page":"2867","DOI":"10.1128\/AAC.00223-07","volume":"51","author":"A Negrea","year":"2007","unstructured":"Negrea A, et al. Salicylidene acylhydrazides that affect type III protein secretion in Salmonella enterica serovar Typhimurium. Antimicrob Agents Chemother. 2007;51:2867\u201376.","journal-title":"Antimicrob Agents Chemother"},{"key":"396_CR20","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1111\/j.1365-2249.2006.03184.x","volume":"146","author":"LN Nesterenko","year":"2006","unstructured":"Nesterenko LN, et al. Mycobacterium tuberculosis-susceptible I\/St mice develop severe disease following infection with taxonomically distant bacteria, Salmonella enterica and Chlamydia pneumoniae. Clin Exp Immunol. 2006;146:93\u2013100.","journal-title":"Clin Exp Immunol"},{"key":"396_CR21","doi-asserted-by":"publisher","first-page":"e00065","DOI":"10.1128\/mBio.00065-13","volume":"4","author":"R Figueira","year":"2013","unstructured":"Figueira R, Watson KG, Holden DW, Helaine S. Identification of salmonella pathogenicity island-2 type III secretion system effectors involved in intramacrophage replication of S. enterica serovar Typhimurium: implications for rational vaccine design. mBio. 2013;4:e00065.","journal-title":"mBio."},{"key":"396_CR22","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1155\/2013\/865671","volume":"2013","author":"NV Kobets","year":"2013","unstructured":"Kobets NV, Nesterenko LN, Balunets DV. Local and systemic immune responses to Salmonella in genetically susceptible I\/St mice after mucosal challenge. ISRN Immunol. 2013;2013:7.","journal-title":"ISRN Immunol."},{"key":"396_CR23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/diseases7010028","volume":"7","author":"L Zha","year":"2019","unstructured":"Zha L, Garrett S, Sun J. Salmonella infection in chronic inflammation and gastrointestinal cancer. Diseases. 2019;7:1\u201314.","journal-title":"Diseases"},{"key":"396_CR24","doi-asserted-by":"publisher","first-page":"1877","DOI":"10.1080\/10807039.2017.1353903","volume":"23","author":"AD Palmer","year":"2017","unstructured":"Palmer AD, Slauch JM. Mechanisms of Salmonella pathogenesis in animal models. Hum Ecol Risk Assess. 2017;23:1877\u201392.","journal-title":"Hum Ecol Risk Assess"},{"key":"396_CR25","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1084\/jem.20031319","volume":"199","author":"DM Monack","year":"2004","unstructured":"Monack DM, Bouley DM, Falkow S. Salmonella typhimurium persists within macrophages in the mesenteric lymph nodes of chronically infected Nramp1+\/+ mice and can be reactivated by IFNgamma neutralization. J Exp Med. 2004;199:231\u201341.","journal-title":"J Exp Med"},{"key":"396_CR26","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1016\/j.tim.2014.06.007","volume":"22","author":"JS Gunn","year":"2014","unstructured":"Gunn JS, et al. Salmonella chronic carriage: epidemiology, diagnosis, and gallbladder persistence. Trends Microbiol. 2014;22:648\u201355.","journal-title":"Trends Microbiol"},{"key":"396_CR27","doi-asserted-by":"publisher","first-page":"1508","DOI":"10.1128\/AEM.01931-07","volume":"74","author":"KA Karatzas","year":"2008","unstructured":"Karatzas KA, et al. Phenotypic and proteomic characterization of multiply antibiotic-resistant variants of Salmonella enterica serovar Typhimurium selected following exposure to disinfectants. Appl Environ Microbiol. 2008;74:1508\u201316.","journal-title":"Appl Environ Microbiol"},{"key":"396_CR28","first-page":"1","volume":"8","author":"M Wang","year":"2020","unstructured":"Wang M, Qazi IH, Wang L, Zhou G, Han H. Salmonella virulence and immune escape. Microorganisms. 2020;8:1\u201325.","journal-title":"Microorganisms"},{"key":"396_CR29","doi-asserted-by":"publisher","first-page":"208","DOI":"10.4161\/viru.2.3.15894","volume":"2","author":"MM Buckner","year":"2011","unstructured":"Buckner MM, Croxen MA, Arena ET, Finlay BB. A comprehensive study of the contribution of Salmonella enterica serovar Typhimurium SPI2 effectors to bacterial colonization, survival, and replication in typhoid fever, macrophage, and epithelial cell infection models. Virulence 2011;2:208\u201316.","journal-title":"Virulence"},{"key":"396_CR30","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/j.chom.2017.07.009","volume":"22","author":"E Jennings","year":"2017","unstructured":"Jennings E, Thurston TLM, Holden DW. Salmonella SPI-2 type iii secretion system effectors: molecular mechanisms and physiological consequences. Cell Host Microbe. 2017;22:217\u201331.","journal-title":"Cell Host Microbe"},{"issue":"Pt 5","key":"396_CR31","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1099\/mic.0.058115-0","volume":"158","author":"R Figueira","year":"2012","unstructured":"Figueira R, Holden DW. Functions of the Salmonella pathogenicity island 2 (SPI-2) type III secretion system effectors. Microbiology. 2012;158(Pt 5):1147\u201361.","journal-title":"Microbiology."},{"key":"396_CR32","doi-asserted-by":"publisher","first-page":"e12","DOI":"10.1017\/S1462399411001840","volume":"13","author":"P Mastroeni","year":"2011","unstructured":"Mastroeni P, Grant AJ. Spread of Salmonella enterica in the body during systemic infection: unravelling host and pathogen determinants. Expert Rev Mol Med. 2011;13:e12.","journal-title":"Expert Rev Mol Med"},{"key":"396_CR33","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1016\/j.tips.2016.05.011","volume":"37","author":"A Anantharajah","year":"2016","unstructured":"Anantharajah A, Mingeot-Leclercq MP, Van Bambeke F. Targeting the type three secretion system in Pseudomonas aeruginosa. Trends Pharm Sci. 2016;37:734\u201349.","journal-title":"Trends Pharm Sci"},{"key":"396_CR34","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1128\/AAC.02566-16","volume":"61","author":"A Anantharajah","year":"2017","unstructured":"Anantharajah A, et al. Salicylidene acylhydrazides and hydroxyquinolines act as inhibitors of type three secretion systems in Pseudomonas aeruginosa by distinct mechanisms. Antimicrob Agents Chemother. 2017;61:1\u201317.","journal-title":"Antimicrob Agents Chemother"},{"key":"396_CR35","doi-asserted-by":"publisher","first-page":"15243","DOI":"10.1074\/jbc.M115.684241","volume":"291","author":"E De Tavernier","year":"2016","unstructured":"De Tavernier E, et al. High throughput combinatorial formatting of PcrV nanobodies for efficient potency improvement. J Biol Chem. 2016;291:15243\u201355.","journal-title":"J Biol Chem"},{"key":"396_CR36","doi-asserted-by":"publisher","first-page":"2249","DOI":"10.1172\/JCI89652","volume":"127","author":"A Thanabalasuriar","year":"2017","unstructured":"Thanabalasuriar A, et al. Bispecific antibody targets multiple Pseudomonas aeruginosa evasion mechanisms in the lung vasculature. J Clin Investig. 2017;127:2249\u201361.","journal-title":"J Clin Investig"},{"key":"396_CR37","first-page":"5","volume":"63","author":"HN Le","year":"2019","unstructured":"Le HN, et al. Treatment efficacy of MEDI3902 in Pseudomonas aeruginosa bloodstream infection and acute pneumonia rabbit models. Antimicrob Agents Chemother. 2019;63:5.","journal-title":"Antimicrob Agents Chemother"},{"key":"396_CR38","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1093\/infdis\/jiw295","volume":"214","author":"A Anantharajah","year":"2016","unstructured":"Anantharajah A, et al. Inhibition of the injectisome and flagellar type iii secretion systems by INP1855 impairs Pseudomonas aeruginosa pathogenicity and inflammasome activation. J Infect Dis. 2016;214:1105\u201316.","journal-title":"J Infect Dis"},{"key":"396_CR39","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1128\/IAI.00595-18","volume":"87","author":"RE McHugh","year":"2019","unstructured":"McHugh RE, O\u2019Boyle N, Connolly JPR, Hoskisson PA, Roe AJ. Characterization of the mode of action of aurodox, a type iii secretion system inhibitor from Streptomyces goldiniensis. Infect Immun. 2019;87:12.","journal-title":"Infect Immun"},{"key":"396_CR40","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1038\/ja.2010.155","volume":"64","author":"K Kimura","year":"2011","unstructured":"Kimura K, et al. A small-molecule inhibitor of the bacterial type III secretion system protects against in vivo infection with Citrobacter rodentium. J Antibiot. 2011;64:197\u2013203.","journal-title":"J Antibiot"}],"container-title":["The Journal of Antibiotics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/s41429-020-00396-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41429-020-00396-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41429-020-00396-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,20]],"date-time":"2023-05-20T17:33:02Z","timestamp":1684603982000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41429-020-00396-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,21]]},"references-count":40,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021,4]]}},"alternative-id":["396"],"URL":"https:\/\/doi.org\/10.1038\/s41429-020-00396-w","relation":{},"ISSN":["0021-8820","1881-1469"],"issn-type":[{"value":"0021-8820","type":"print"},{"value":"1881-1469","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1,21]]},"assertion":[{"value":"24 September 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 November 2020","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 November 2020","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 January 2021","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}